The hereditary cancer testing global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Hereditary Cancer Testing Market, 2024 report by The Business Research Company
offers comprehensive insights into the current state of the market and
highlights future growth opportunities.
Market Size -
The hereditary cancer testing market size has grown rapidly in recent years. It
will grow from $3.97 billion in 2023 to $4.43 billion in 2024 at a compound
annual growth rate (CAGR) of 11.6%. The
growth in the historic period can be attributed to rising incidence of
hereditary cancers, genetic counseling programs, government initiatives for
cancer prevention, improved insurance coverage, understanding of
gene-environment interactions, patient advocacy and support groups.
The hereditary cancer testing market size is expected to see rapid growth in
the next few years. It will grow to $6.7 billion in 2028 at a compound annual
growth rate (CAGR) of 10.9%. The growth
in the forecast period can be attributed to expansion of targeted therapies,
advancements in precision medicine, rise in direct-to-consumer testing, global
health initiatives, advancements in bioinformatics. Major trends in the
forecast period include advancements in genetic sequencing technologies,
telemedicine and remote genetic counseling, precision medicine and personalized
treatment, cancer risk assessment models, ethical and legal considerations.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report
Scope Of Hereditary Cancer Testing Market
The Business Research Company's reports encompass a wide range of information,
including:
1. Market Size (Historic and Forecast): Analysis of the market's historical
performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market
landscape.
4. Key Segments: Breakdown of the market into its primary segments and their
respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and
geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting
the market.
Hereditary Cancer Testing Market Overview
Market Drivers -
The increasing prevalence of hereditary cancer is expected to drive the
hereditary cancer testing market. Mutations in specific genes passed down from
parents to children cause hereditary cancer syndromes. Hereditary cancer
testing can detect specific, heritable, disease-related gene mutations,
allowing for a comprehensive cancer risk assessment for patients. For instance,
in June 2022, according to an article published on BioMed Central about
hereditary cancer in clinical practise, about 10% of pancreatic cancer cases
have a genetic background. Furthermore, in May 2021, a Europe-based software
company called SOPHiA Genetics, a data-driven medicine software company, stated
in an article that hereditary factors account for approximately 10% of cancer
cases, with an estimated 20% of cancer patients having a cancer family history.
Therefore, the increasing prevalence of hereditary cancer drives the growth of
the hereditary cancer testing market.
Market Trends -
Technological innovation is a key trend gaining popularity in the hereditary
cancer testing market. Key players in the market are focusing on technological
innovations to sustain their market positions. For instance, in March 2022,
Myriad Genetics, a US-based genetic testing and precision medicine company,
launched genetic testing with a Polygenic Breast Cancer Risk Assessment Score
for all ancestries. This MyRisk Hereditary Cancer test with RiskScore offers a
personalized breast cancer risk assessment to all women who have never been
diagnosed with breast cancer, regardless of ancestry.
The hereditary cancer testing market covered in this report is segmented –
1) By Test Type: Multi Panel Test, Single-site Genetic Test
2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other
Indications
3) By End user: Hospital, Clinics, Diagnostic Centers
Get an inside scoop of the hereditary cancer testing market, Request now for
Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=8121&type=smp
Regional Insights -
North America was the largest region in the hereditary cancer testing market in
2023. The regions covered in the hereditary cancer testing market report are
Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East, Africa.
Key Companies -
Major companies operating in the hereditary cancer testing market report are
Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics
Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics
Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc.,
Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc.,
Laboratory Corporation of America Holdings, Pathway Genomics Corporation,
Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated
Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F.
Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent
Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc.,
Oxford Nanopore Technologies plc, PerkinElmer Inc.
Table of Contents
1. Executive Summary
2. Hereditary Cancer Testing Market Report Structure
3. Hereditary Cancer Testing Market Trends And Strategies
4. Hereditary Cancer Testing Market – Macro Economic Scenario
5. Hereditary Cancer Testing Market Size And Growth
…..
27. Hereditary Cancer Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment